Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

8.63
Delayed Data
As of Aug 17
 -0.07 / -0.80%
Today’s Change
7.41
Today|||52-Week Range
24.93
-47.60%
Year-to-Date
Endo International (ENDP) Jumps: Stock Rises 6.9%
Aug 17 / Zacks.com - Paid Partner Content
Endo (ENDP) Q2 Earnings Beat Estimates, 2017 Guidance Cut
Aug 08 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) Q2 Loss Wider than Expected, Stock Falls
Aug 10 / Zacks.com - Paid Partner Content
What's in Store for BioDelivery (BDSI) This Earnings Season?
Aug 07 / Zacks.com - Paid Partner Content
Endo (ENDP) Beats Q2 Earnings & Sales, 2017 Guidance Lowered
Aug 08 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close8.70
Today’s open8.58
Day’s range8.57 - 9.06
Volume8,887,698
Average volume (3 months)6,733,150
Market cap$1.9B
Dividend yield--
Data as of 08/17/2017

Growth & Valuation

Earnings growth (last year)-96.37%
Earnings growth (this year)-25.41%
Earnings growth (next 5 years)-7.30%
Revenue growth (last year)+22.69%
P/E ratioNM
Price/Sales0.91
Price/Book0.71

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...+2.60+4.98%
FOLDAmicus Therapeutics ...-0.31-2.46%
PRTAProthena Corporation...-2.46-4.26%
LOXOLoxo Oncology Inc-2.69-3.63%
Data as of 08/17/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.76
Annual revenue (last year)$4.0B
Annual profit (last year)-$3.3B
Net profit margin-80.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul V. Campanelli
Chief Operating Officer &
Executive Vice President
Terrance J. Coughlin
Corporate headquarters
Dublin, Dublin

Forecasts